Health Information Management

Tip: I/OCE update brings new APCs

APCs Insider, June 6, 2014

Want to receive articles like this one in your inbox? Subscribe to APCs Insider!

Two APCs were added with an effective date of January 1, 2014, and assigned status indicator K (non-pass-through drugs and non-implantable biologicals, including therapeutic radiopharmaceuticals):
  • 01477, injection, tbo-filgrastim, 5 mcg
  • 01478, human fibrinogen concentrate injection 
CMS also added two APCs with an effective date of April 1, 2014, with status indicator G (pass-through drugs and biologicals):
  • 01476, injection, obinutuzumab
  • 01479, TheraSkin
CMS deleted APC 01645 (I131 tositumomab, rx) effective April 1, 2014.
 
This tip is adapted from “CMS refines skin substitute packaging” in the June issue of Briefings on APCs.



Want to receive articles like this one in your inbox? Subscribe to APCs Insider!

    Briefings on APCs

  • Briefings on APCs

    Worried about the complexities of the new rules under OPPS and APCs? Briefings on APCs helps you understand the new rules...

  • HIM Briefings

    Guiding Health Information Management professionals through the continuously changing field of medical records and toward a...

  • Briefings on Coding Compliance Strategies

    Submitting improper Medicare documentation can lead to denial of fees, payback, fines, and increased diligence from payers...

  • Briefings on HIPAA

    How can you minimize the impact of HIPAA? Subscribe to Briefings on HIPAA, your health information management resource for...

  • APCs Insider

    This HTML-based e-mail newsletter provides weekly tips and advice on the new ambulatory payment classifications regulations...

Most Popular